Delivery Order SPE2DE24D0013-SPE2D626F47XF

The Defense Logistics Agency Medical Supply Chain issued a delivery order to Cepheid on February 5, 2026, with a ceiling value of $1,477.60 and an ultimate completion date of February 12, 2026. This is a firm fixed-price delivery order placed against Cepheid's existing supply relationship with DLA Medical Supply Chain. Place of performance is Sunnyvale, CA 94089. The order represents a call for diagnostic supplies or reagents within Cepheid's established federal molecular diagnostics procurement...

<p>The Defense Logistics Agency Medical Supply Chain issued a $11,040 delivery order to Cepheid on February 6, 2026, for molecular diagnostic supplies with an ultimate completion date of February 13, 2026. Place of performance is Sunnyvale, CA. The order is firm fixed price with no set-aside designation.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a $2,024.00 delivery order to Cepheid on February 5, 2026, with ultimate completion on February 12, 2026. Place of performance is Sunnyvale, California. The order is firm fixed price with no set-aside.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued an $8,640 delivery order to Cepheid on February 6, 2026, for diagnostic supplies under a firm fixed-price structure. Place of performance is Sunnyvale, CA. The order has an ultimate completion date of February 13, 2026.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a $3,194.60 delivery order to Cepheid on February 5, 2026, for diagnostic test kits with an ultimate completion date of February 12, 2026.</p> <p>Place of performance is Sunnyvale, CA 94089. The order is priced on a firm fixed-price basis with no set-aside used.</p>

The Defense Logistics Agency Medical Supply Chain issued a $6,800 delivery order to Cepheid on February 5, 2026, under a parent Indefinite Delivery Contract for molecular diagnostic reagents and test kits. Place of performance is Sunnyvale, CA 94089. The order has a firm fixed-price structure with an ultimate completion date of February 12, 2026. The delivery covers diagnostic testing supplies supporting Cepheid's GeneXpert diagnostic platform, which provides molecular testing for infectious...

The Defense Logistics Agency Medical Supply Chain issued a $5,440 delivery order to Cepheid on February 5, 2026, for molecular diagnostic testing supplies with an ultimate completion date of February 12, 2026. Place of performance is Sunnyvale, CA 94089. The order is firm fixed price with no set-aside. The source does not identify the parent vehicle by name; however, Cepheid holds related Indefinite Delivery Contracts with the Department of Veterans Affairs for molecular diagnostic reagents...

On January 21, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,720 to Cepheid Inc. for diagnostic supplies. This firm fixed-price delivery order, issued under the XPRS4PLEX-10 contract with an ultimate completion date of January 28, 2026, represents a child order under a larger Indefinite Delivery Vehicle. The award carries no set-aside designation and is being performed in Sunnyvale, California, where Cepheid is headquartered. The delivery order...

The U.S. Defense Department's Medical Supply Chain awarded a $2,720 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The delivery order, issued on July 14, 2025, with an ultimate completion date of July 21, 2025, carries no set-aside designation. Performance will take place in Sunnyvale, CA. This award represents a relatively modest transaction within Cepheid's broader federal contracting portfolio, which centers on...

The Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $1,190.28 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California. This firm fixed-price delivery order, issued on June 6, 2025, with an ultimate completion date of June 23, 2025, carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic testing solutions to federal defense and healthcare...